Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients;Linfomas del tubo digestive y glándulas anexas en pacientes con SIDA. Serie de casos

Acta Gastroenterologica Latinoamericana

Volumn 36, Issue 4, 2006, Pages 190-196

  Corti, Marcelo ^a,d   Fioti, María F Villafañe ^a   Lewi, Daniel ^b   Schtirbu, Ricardo ^a   Narbaitz, Marina ^c   De Dios Soler, Marcela ^c  

^a HOSPITAL F J MUÑIZ   (Argentina)

^b HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^c ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^d Ciudad Autónoma de Buenos Aires ^*  (Argentina)

Author keywords

AIDS; Digestive tract; HIV; Lymphoma

Indexed keywords

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER STAGING; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; LIVER TUMOR; MALE; MORTALITY; NONHODGKIN LYMPHOMA; PAROTID GLAND TUMOR; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN; MALE; NEOPLASM STAGING; PAROTID NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33845366510     PISSN: 03009033     EISSN: 03009033     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Gurney KA, Cartwright RA, Gilman EA. Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population based registry. Br J Cancer 1999;79:1929-1934.
2. Stephens J, Smith J. Treatment of primary gastric lymphoma and gastric mucosa-associated lymphoid tissue lymphoma. J Am Coll Surg 1998;187:312-320.
3. Weisenburger DD. Epidemiology of non-Hodgkin's lymphoma. Recent findings regarding an emerging epidemia. Ann Oncol 1994;8:S19-S24.
4. Galindo F, Fernández Marty P, Kogan A, Diaz S, Barujel ME, dos Santos R. Linfomas de intestino delgado y cirugía. Rev Argent Cirug 1996;70:157-167.
5. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal cutaneous and genitourinary lymphomas. Ann Oncol 1997;8:727-737.
6. Weiss LM, Chen Y-Y, Liu X-F, Shibata D. Epstein Barr virus and Hodgkin's disease. A correlative in situ hybridization and polimerase chain reaction study. Am J Pathol 1991;139:1259-1265.
7. Corti ME, Villafañe MF, Trione N, Schtirbu R, Yampolsky C, Narbaitz, M. Linfomas primarios del sistema nervioso central en pacientes con SIDA. Enferm Infecc Microbiol Clin 2004;22:332-336.
8. Corti M, Villafañe MF, Trione N, Narbaitz M. Linfoma de Hodgkin asociado a la infección por VIH-1: análisis epidemiológico, clínico y virológico e histopatológico en 18 pacientes. Med Clín (Barcelona) 2005;124:116-117.
9. Corti M, Villafañe MF, Schtirbu R, Lewi D. Tumoración de parótida en un paciente con SIDA. Enferm Infecc Microbiol Clin 2003;21:597-598.
10. Corti M. Villafañe MF, Cermelj M, Candela M, Pérez Bianco R, Tezanos Pinto M. Linfoma de cavum en un paciente hemofilico con SIDA. Medicina (Buenos Aires) 2000;60:351-353.
11. Corti M, Villafañe MF, Soto I, Narbaitz M, Castro Rios M, Corti R, et al. Linfoma primario de esófago en un paciente con SIDA. A Ge La 2003;33:155-158
12. Ioachim HL, Dorsett B, Cronin W, Maya M, Wahl S. Acquired immunodeficiency syndrome associated lymphomas: clinic, pathologic, immunologic and viral characteristics of 11 cases. Hum Pathol 1991;7:659-673.
13. Carrieri MP, Pradier C, Piselli P, Piche M, Rosenthal E, Heudier P, et al. Reduced incidence of Kaposi's sarcoma and systemic non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral dierapy. Int J Cancer 2003;103:142-144.
14. Tirelli U, Spina M, Gaidano G, Vaccher E, Franceschi S, Carbone A. Epidemiological, biological and clinical features of HIV-related lymphomas in the era of highly active antiretroviral therapy. AIDS 2000;14:1675-1688.
15. Gerard L, Galicier L, Maillard A, Boulanger E, Quint L, Matheron S, et al. Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. J Acquir Immune Defic Syndr 2002;30:478-484.
16. Ribera JM, Navarro JT. Linfomas en pacientes con infección por el VIH. Las cosas han cambiado para bien. Enferm Infecc Microbiol Clin 2004;22:313-314.
17. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, Levine AM, Lukes RJ, et al. Non-Hodgkin's lymphoma in 90 homosexual men: relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome (AIDS). N Eng J Med 1984;311:565-570.
18. Levine AM, Gill PS, Meyer PR, Burkes RL, Ross R, Dworsky RD, et al. Retrovirus and malignant lymphomas in homosexual men. JAMA 1985;254:1921-1925.
19. Ioachim HL, Cooper MC, Hellamn GC. Lymphomas in men at high risk for acquired immunodeficiency syndrome (AIDS). Cancer (Phila.) 1985;56:2831-2842.
20. Ioachim HL, Ryan JR, Blaugrund SM. Salivary glands lymph nodes: the site of lymphadenopathies and lymphomas associated with human immunodeficiency virus infection. Arch Pathol Lab Med 1988;112:1224-1228.
21. Biggar RJ, Rabkin CS. The epidemiology of acquired immunodeficiency syndrome-related lymphomas. Curr Opin Oncol 1992;4:883-893.
22. Ministerio de Salud y Ambiente de la Nación. Boletin sobre VIH/SIDA en la Argentina 2004;11:1-56.
23. Chun TW, Fauci AS. Latent reservoirs of HIV: obstacles to the eradication of virus. Proc Natl Acad Sci U S A 1999;96:10958-10961.
24. Levine AM, Gill PS, Meyer PR, Burkes RL, Ross R, Dworsky RD, et al. Retrovirus and malignant lymphomas in homosexual men. JAMA 1985;254:1921-1925.
25. Levine AM, Gill PS. AIDS-related malignant lymphoma: clinical presentation and treatment approaches. Oncology 1987;1:41-46.
26. Hamilton-Dutoit SJ, Pallesen G, Karkov J, Skinjoj P, Franzmann MB, Pedersen C. Identification of EBV-DNA in tumor cells of AIDS-related lymphomas by in-situ hybridization. Lancet 1989;1:554-555.
27. Ganser A, Carlo-Stella C, Bartram CR, Boehm T, Heil G, Henglein B, et al. Establishment of two Epstein-Barr virus negative Burkitt cell lines from a patient with AIDS and B-cell lymphoma. Blood 1988;72:1255-1260.
28. Durberg AS, Nordstrom M, Torner A, Reichard O, Strauss R, Janzon R, Back E, Ekdahl K. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology 2005;4:652-659.
29. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:392-394.
30. De Rosa G, Gobbo ML, De Renzo A, Notaro R, Garofalo S, Grimaldi M, et al. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol 1997;55:77-82.
31. Navarro JT, Ribera JM, Lloveras N, Oriol A, Mate JL, Bade M, et al. HIV-infected patients with diffuse large B-cell lymphoma treated with CHOP and HAART have similar outcome than HIV-negative patients receiving CHOP. Abstract 2370. Blood 2003;102:642a.
32. Navarro JT, Ribera JM, Oriol A, Tural C, Millá F, Feliu E. Improved outcome of AIDS-related lymphoma in patients with virologie response to highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003;32:347-348.
33. Hoffmann C, Wolf E, Fätkenheuer G, Buhk T, Stoehr A, Plettenberg A, et al. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma. AIDS 2003;17:1521-1529.
34. Mizorogi F, Hiramoto J, Nozato A, Takekuma Y, Nagayama K, Tanaka T, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma. Intern Med 2000;39:112-117.
35. Kaplan LD, Abrams DI, Feigal E, McGrath M, Kahn J, Neville P, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989;261:719-724.
36. Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP, et al. Randomized trial of standard-dose vs low-dose mBACOD chemotherapy for HIV-associated non-Hodgkin's lymphoma. N Eng J Med 1997:336:1641-1648.
37. Levine AM. Acquired immunodeficiency AIDS-related lymphoma. Blood 1992;80:8-20.
38. Re A, Cattaneo C, Michieli M, Casari S, Spina M, Rupolo M, et al. High- dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 2003;21:4423-4427.